Evidence map›Paper›PMID 37356985›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Clinical study of induction chemotherapy followed by allogeneic hematopoietic stem cell transplantation in the treatment of FLT3-ITD(+) acute myeloid leukemia with normal karyotype].

F Li, Y P Liu, H Zhu, M Hong, S X Qian, Y Zhu, W Y Shen, L J Chen, G S He, H X Wu and 3 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

F LiDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Y P LiuDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
H ZhuDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
M HongDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
S X QianDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Y ZhuDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
W Y ShenDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
L J ChenDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
G S HeDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
H X WuDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
H LuDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
J Y LiDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
K R MiaoDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Jiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Induction ChemotherapyLeukemia, Myeloid, AcuteTransplantation, HomologousFemalefms-Like Tyrosine Kinase 3HumansMalePrognosisRetrospective StudiesSurvivalFLT3 protein, humanfms-Like Tyrosine Kinase 3Allogeneic hematopoietic stem cell transplantationFLT3-ITD mutationLeukemia, myeloid, acutePrognosis

Identifiers

PMID37356985
PMCPMC10119728
OpenAlexW4382010943

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.